As of May 01
| +0.41 / +6.13%|
The 2 analysts offering 12-month price forecasts for ChemoCentryx Inc have a median target of 9.50, with a high estimate of 12.00 and a low estimate of 7.00. The median estimate represents a +33.80% increase from the last price of 7.10.
The current consensus among 4 polled investment analysts is to Hold stock in ChemoCentryx Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.